When was Anzen Industries founded?

Anzen Industries was founded in 2017 and raised its 1st funding round 9 years after it was founded.

Where is Anzen Industries located?

Anzen Industries is headquartered in San Francisco, United States.

How many employees does Anzen Industries have?

As of Apr 30, 2026, the latest employee count at Anzen Industries is 4.

Is Anzen Industries a funded company?

Anzen Industries is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 19, 2026.

When was the latest funding round of Anzen Industries?

Anzen Industries' latest funding was a $***** Seed round on Jan 19, 2026, with participation from 4 investors.

Where does Anzen Industries rank among its competitors?

Anzen Industries ranks 3rd amongst 5 active competitors, of which 4 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Imperagen, which secured $6.71M in May, 2026.

Who are the top competitors of Anzen Industries?

Anzen Industries' top competitors include Imperagen, ZYMVOL and Shanghai Bima Life Sciences. Among them, Imperagen secured the most recent funding round in May, 2026.

Anzen Industries - 2026 Company Profile, Funding & Competitors

Anzen Industries is a seed company based in San Francisco (United States), founded in 2017. It operates as a Developer of technology to stabilize enzymes for chemical production outside cells. Anzen Industries has raised $2.2M in funding from LocalGlobe and Creator Fund. The company has 5 active competitors, including 4 that are funded. Its top competitors include companies like Imperagen, ZYMVOL and Shanghai Bima Life Sciences.

Company Details

Developer of technology to stabilize enzymes for chemical production outside cells. It focuses on isolating and stabilizing enzymes responsible for specific reactions. This enables the same reaction to occur outside of a cell. The technology immobilizes enzymes in modular reactors. This allows for scaling chemical production and complete supply chain control.

Website: anzenindustries.com
Email ID: *****@anzenindustries.com

Key Metrics

Founded Year

2017

Location

San Francisco, United States

Stage

Seed

Total Funding

$2.2M in 1 round

Latest Funding Round

Seed, Jan 19, 2026, $*****

Investors

LocalGlobe & 3 more

Ranked

3^rd among 5 active competitors

Employee Count

4 as on Apr 30, 2026

Similar Companies

Imperagen & 3 more

View Anzen Industries' full profile

Anzen Industries has raised a total funding of $2.2M over 1 round. Its latest funding round was a Seed round on Jan 19, 2026 for $*****. 4 investors participated in its latest round. Anzen Industries has 2 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Anzen Industries:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 19, 2026	8508071	Seed	6384230	9466072	3645883	9562286

Access funding benchmarks and valuations. Sign up today!

View details of Anzen Industries's funding rounds and investors

Anzen Industries' employee count trend

Anzen Industries has 4 employees as of Apr 26. Here is Anzen Industries's employee count trend over the years:

Employee count trend for Anzen Industries

Uncover Anzen Industries' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Anzen Industries include Imperagen, ZYMVOL and Shanghai Bima Life Sciences. Here is the list of Top 10 competitors of Anzen Industries, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Imperagen 2021, Manchester (United Kingdom), Seed	Developer of enzyme engineering platform for drug development	$11.4M	IQ Capital, PXN Ventures & 1 others	51/100
2nd	ZYMVOL 2017, Barcelona (Spain), Seed	Provider of enzyme engineering services using computational and AI-driven molecular modeling	$4.52M	Faber, Elaia & 3 others	41/100
3rd	Anzen Industries 2017, San Francisco (United States), Seed	Developer of technology to stabilize enzymes for chemical production outside cells	$2.2M	LocalGlobe, Creator Fund & 2 others	36/100
4th	Shanghai Bima Life Sciences Seed	Provider of proteomics detection platform based on antibody affinity assay	-	-	24/100
5th	DirectBio 2023, San Francisco (United States), Unfunded	Provider of diagnostic assays utilizing AI-engineered CRISPR enzymes	-	-	15/100